ePosters - Inecalcitol Stimulates CD38 Expression in Multiple Myeloma and Acute Myeloid Leukemia Cell Lines
Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients | Haematologica
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formatio
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model | Journal of Nuclear Medicine
Frontiers | Daratumumab for the Treatment of Multiple Myeloma
Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents
Immunophenotyping in Multiple Myeloma and Others Monoclonal Gammopathies | IntechOpen
Cureus | CD38: From Positive to Negative Expression after Daratumumab Treatment | Article
International Clinical Cytometry Society
New Strategies for Targeting CD38 in Multiple Myeloma Take Root
![Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.1c00733/asset/images/acs.molpharmaceut.1c00733.social.jpeg_v03 "Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics")
Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics
CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
Immunophenotyping | plasma cells | human multiple myeloma bone marrow | Protocol | Italia
Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
Expression of CD38 in normal and malignant plasma cells.... | Download Scientific Diagram
CD38 - Wikipedia
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
Functional multi-omics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma | bioRxiv
CD38 directed therapies for management of multiple myeloma | ITT
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia
Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma Immunotherapy | Semantic Scholar
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes | SpringerLink
